Is Halozyme Therapeutics, Inc. (HALO) a Buy, Sell, or Hold?
NASDAQ : HALO
Halozyme Therapeutics, Inc. — Analyst Ratings
$83.03 USD
-$0.41 (-0.5%)
- Volume
- 199.72K
- Average Volume
- 1.81M
- Market Capitalization
- $9.85B
- P/E Ratio
- 28.43
- Dividend Yield
- 0.00%
- Price Target
- $91.50
- Year High
- $84.44
- Year Low
- $58.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.76
Analyst Consensus Summary
Consensus Rating
Neutral
27 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-9.3%
vs Current Price
Price Target
$91.50
Average TargetPrice Target Range
Lowest Target
$75.00
10.7% UPSIDE
Average Target
$91.50
Median Estimate
Highest Target
$95.00
-12.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 27
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 17 | 9 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Mitchell Kapoor | $95 | $63.86 | 2026-04-29 06:10 AM | 48.8% |
| Goldman Sachs | Corinne Jenkins | $56 | $62.815 | 2025-12-04 06:51 AM | -10.8% |